Diagnos Inc (TSE:ADK) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Diagnos Inc. has enhanced its board of directors by appointing Michael Braeuel, an entrepreneur with over three decades of business experience and expertise in machine vision inspection technology. The company, recognized for its innovative Artificial Intelligence platform FLAIRE, anticipates Braeuel’s experience will significantly contribute to its growth. Diagnos specializes in early detection of critical health issues, including the use of its AI-driven application CARA for retina analysis.
For further insights into TSE:ADK stock, check out TipRanks’ Stock Analysis page.
